FLDT(SH:600228)2019-10-18 16:00Financial Performance - Operating revenue for the period was CNY 329,552,496.65, representing an 18.00% decline year-on-year [5]. - Net profit attributable to shareholders was a loss of CNY 3,694,338.35, a decrease of 145.20% compared to the same period last year [5]. - The weighted average return on equity was -6.20%, a decrease of 20.66 percentage points from the previous year [5]. - Basic and diluted earnings per share were both -CNY 0.02, a decline of 166.67% year-on-year [5]. - The company anticipates a potential net loss for the year due to challenges in the acrylamide business and uncertainties in the private equity fund management sector [13]. - Total operating revenue for Q3 2019 was CNY 114,698,597.70, a decrease of 14.2% compared to CNY 133,729,539.10 in Q3 2018 [23]. - Net profit for Q3 2019 was CNY 5,274,314.12, a decrease of 15.6% compared to CNY 6,251,605.18 in Q3 2018 [24]. - The company reported a total profit of CNY 6,803,639.14 for Q3 2019, compared to CNY 7,500,770.35 in Q3 2018, reflecting a decline of 9.3% [24]. - The company’s total comprehensive income for Q3 2019 was CNY 5,274,314.12, down from CNY 6,251,605.18 in Q3 2018 [25]. - The net profit for Q3 2019 was -3,335,510.26 RMB, compared to a net profit of 3,364,363.62 RMB in Q3 2018, indicating a significant loss [27]. - The total profit for the first three quarters of 2019 was -5,758,371.09 RMB, compared to a profit of 3,364,363.62 RMB in the same period of 2018 [27]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 3,456,289.32, compared to a negative cash flow of CNY 4,643,372.98 in the same period last year [5]. - Cash and cash equivalents decreased by 32.56% from CNY 61,834,457.32 to CNY 41,699,404.30, primarily due to reduced borrowing and decreased revenue [10]. - The ending cash and cash equivalents balance was CNY 41,699,404.30, down from CNY 61,834,457.32 at the beginning of the period [30]. - The company incurred cash payments of CNY 6,451,400.91 to employees, which is an increase from CNY 3,590,904.42 in the same period last year [33]. - The total cash outflow for operating activities was CNY 18,244,020.95, which is a significant increase compared to CNY 9,753,686.21 in the previous year [33]. - The cash flow from investment activities showed a significant improvement with a net cash flow of CNY 9,643,429.62 compared to a negative cash flow of CNY -16,454,803.03 in the previous year [33]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 266,901,463.80, a decrease of 7.01% compared to the end of the previous year [5]. - Total liabilities decreased from ¥152,404,209.67 to ¥137,292,393.25, a decline of around 9.9% [18]. - Owner's equity decreased from ¥134,608,945.13 to ¥129,609,070.55, a reduction of about 3.7% [18]. - Current liabilities decreased from ¥117,970,354.47 to ¥102,929,462.38, a reduction of about 12.7% [17]. - Non-current liabilities remained relatively stable, with a slight decrease from ¥34,433,855.20 to ¥34,362,930.87, a change of approximately 0.2% [18]. - The total liabilities to equity ratio improved from 1.13 to 1.06, indicating a decrease in financial leverage [18]. - The company reported a negative retained earnings of ¥-552,419,318.66, slightly worsening from ¥-548,724,980.31 [18]. - The company reported a negative retained earnings of CNY -548,724,980.31 [38]. Shareholder Information - The total number of shareholders at the end of the reporting period was 14,340 [8]. - The largest shareholder, Jiangxi Changjiu Group Co., Ltd., held 61,733,394 shares, accounting for 25.58% of the total shares, with all shares pledged [9]. Operational Insights - The company has not disclosed any new product developments or market expansion strategies in this report [5]. - The company is actively following up on the production line merger project for safety compliance and has not yet received formal approval for the project [11]. - Research and development expenses for the first three quarters of 2019 totaled CNY 11,235,855.27, slightly down from CNY 11,692,179.86 in the same period of 2018 [23]. - The company reported a significant increase in credit impairment losses, with 640,055.96 RMB in the first three quarters of 2019 compared to a recovery of -1,313,453.02 RMB in the same period of 2018 [26].